Attached files
| file | filename |
|---|---|
| 10-K - 10-K - IMMUNE DESIGN CORP. | imdz-form10xk2017.htm |
| EX-32.2 - EXHIBIT 32.2 - IMMUNE DESIGN CORP. | ex32220171231.htm |
| EX-32.1 - EXHIBIT 32.1 - IMMUNE DESIGN CORP. | ex32120171231.htm |
| EX-31.2 - EXHIBIT 31.2 - IMMUNE DESIGN CORP. | ex31220171231.htm |
| EX-31.1 - EXHIBIT 31.1 - IMMUNE DESIGN CORP. | ex31120171231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-197748, No. 333-203143, No. 333-211264, and No. 333-217831 and Form S-3 No. 333-206324) of Immune Design Corp. of our report dated March 14, 2018, with respect to the consolidated financial statements of Immune Design Corp. included in this Annual Report (Form 10-K) for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Redwood City, California
March 14, 2018